P. Tajik MD PhD

foto

MD PhD P. Tajik

Position
Other Academic Staff
Main activities
Research
Specialisation
Development and Evaluation of Biomarkers for Predicting Treatment Effects in Clinical Trials: Method
Focus of research

1. Developing methods for identification and evaluation of markers to guide treatment decisions

2. Identification and evaluation of markers for guiding treatments for ovarian cancer patients

 

Amsterdam UMC Research Institutes
AMC departments
Key publications
  • Tajik P., van der Ham D. P., Zafarmand M. H., Hof M. H. P., Morris J., Franssen M. T. M., de Groot C. J. M., Duvekot J. J., Oudijk M. A., Willekes C., Bloemenkamp K. W. M., Porath M., Woiski M., Akerboom B. M., Sikkema J. M., Nij Bijvank B., Mulder A. L. M., Bossuyt P. M., Mol B. W. J. Using vaginal Group B Streptococcus colonisation in women with preterm premature rupture of membranes to guide the decision for immediate delivery: a secondary analysis of the PPROMEXIL trials BJOG 2014;121 (10):1263-72; discussion 1273 [PubMed]
  • Tajik Parvin, Zwinderman Aleiko H., Mol Ben W., Bossuyt Patrick M. Trial designs for personalizing cancer care: a systematic review and classification Clinical cancer research 2013;19 (17):4578-4588 [PubMed]
  • Tajik Parvin, Bossuyt Patrick M. Genomic markers to tailor treatments: waiting or initiating? Human genetics 2011;130 (1):15-18 [PubMed]
  • Tajik Parvin Markers to guide treatment decisions: Methods and applications in obstetrics and gynecology 2015. 196p. ISBN 9789462595750. [UvA Dissertations Online]
  • van Meurs Hannah S., Tajik Parvin, Hof Michel H. P., Vergote Ignace, Kenter Gemma G., Mol Ben Willem J., Buist Marrije R., Bossuyt Patrick M. Which patients benefit most from primary surgery or neoadjuvant chemotherapy in stage IIIC or IV ovarian cancer? An exploratory analysis of the European Organisation for Research and Treatment of Cancer 55971 randomised trial European journal of cancer (Oxford, England 2013;49 (15):3191-3201 [PubMed]
All Publications
Research programmes

Prof. PhD P.M.M. Bossuyt (BIomarker and Test Evaluation program (BITE))

Prof. MD PhD G.G. Kenter (gynaecologic Oncology)